Vétoquinol S.A., a veterinary pharmaceutical laboratory, designs, develops, and sells veterinary drugs and non-medicinal products serving both the companion animals and livestock, and bred for human food markets in Europe, the Americas, and the Asia Pacific region. It offers pain management, anti-infective, cardiology-nephrology, care and hygiene, antiparasiticides, behavior, internal medicine, and reproduction related products for dogs, cats, cattle, and pigs. The company offers its prdoucts under Tolfedine CS, Tolfine, Cimalgex, Flexadin, Caniviton, Diurizone, Marbocyl, Forcyl, Ceftiocyl, Clavaseptin, Clindaseptin, Cefaseptin, Kefloril, Aurizon, Oridermyl, Longamox, Pen-Histra-Strep, Doxicor, Amoxinsol, Aluspray, Linspec, Permacyl, UpCard, Prilium, Ipakitine/Epakitine, Azodyl, Rubenal, Flevox, Dolpac, Zylkene, and Zentonil brands. The company was founded in 1933 and is headquartered in Lure, France. Vétoquinol S.A. is a subsidiary of Soparfin SCA.
Lure, FR
Size (employees)
2,084 (est)+3%
Vetoquinol was founded in 1933 and is headquartered in Lure, FR

Vetoquinol Office Locations

Vetoquinol has an office in Lure
Lure, FR (HQ)
BP 189

Vetoquinol Financials and Metrics

Vetoquinol Financials


Market capitalization (20-Oct-2017)

638.2 m

Closing share price (20-Oct-2017)

Vetoquinol's current market capitalization is €638.2 m.
Show all financial metrics

Vetoquinol Market Value History

Traffic Overview of Vetoquinol

Vetoquinol Online and Social Media Presence

Vetoquinol News and Updates

Global Farm Animals Drugs Market Driven by Increasing Focus on Preventive Healthcare

Future Market Insights has announced the addition of the “Farm Animals Drugs Market: Global Industry Analysis and Opportunity Assessment, 2017-2027"report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday

Vetoquinol Company Life and Culture

You may also be interested in